-
Newer biomarkers such as B-type natriuretic peptide (BNP) and high-sensitive troponins have been shown to be of prognostic value in patients with cardiovascular disease. These investigators from central Europe sought to determine if they were of value in risk stratification for non-cardiac surgery.
-
The prevalence and natural history of aortic stenosis (AS) are well known. However, there is a paucity of data about the natural history of combined AS and aortic regurgitation (AR). AS and AR confer differing types of stress on the left ventricle, and it stands to reason that the combination may result in worse outcomes than either AS or AR alone.
-
Chelation therapy for cardiovascular disease; statins and kidney injuries; chlorthalidone for hypertension; and FDA actions.
-
In this paper, the authors report the results of a study that examined the impact of yoga training on patients with paroxysmal atrial fibrillation (AF). The authors enrolled 101 patients with paroxysmal AF who were on a stable medical regimen.
-
-
Overnight observation in the hospital after PCI remains the standard of care in the United States. However, because of the low complication rates, there has been a move toward same-day discharge in some countries.
-
Evidence-based updates in primary care medicine By Louis Kuritzky, MD
-
Given the high prevalence of MVP in the general population, a true association with SCA risk has been controversial.
-
-
Dabigatran etexilate, a direct thrombin inhibitor, is one of a new class of oral anticoagulants that was recently demonstrated in a Phase 3 trial to be effective for the prevention of stroke or systemic embolism (SSE) in patients with atrial fibrillation (AF).
